Dual-action compounds show promise against aggressive cancer and infections

Chemists develop dual-action compounds to fight cancer and infections

Cancer patients often face more than the disease itself. Their treatment is frequently complicated by infections and other health conditions, meaning they may need to take several different medications at once. As the number of prescribed drugs increases, so does the risk of interactions between them, which is why scientists are searching for solutions that could one day address multiple problems with a single compound.

Dual-action compounds show promise against aggressive cancer and infections

Cancer patients often face more than the disease itself. Their treatment is frequently complicated by infections and other health conditions, meaning they may need to take several different medications at once.

KTU chemists create dual-action compounds targeting cancer and infections

Cancer treatment is rarely limited to the cancer itself. Patients with advanced disease may also develop bacterial or fungal infections, while other medical conditions can require additional medicines. As the number of drugs taken by a patient rises, so does the possibility of adverse interactions, overlapping toxicities and treatment complications. This challenge has encouraged researchers to look beyond conventional “one drug, one target” stra…